false
0000788920
0000788920
2026-02-09
2026-02-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 9, 2026
PRO-DEX, INC.
(Exact name of registrant as specified in charter)
| Colorado |
0-14942 |
84-1261240 |
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
2361 McGaw Avenue
Irvine, California 92614
(Address of principal executive offices, zip
code)
(949) 769-3200
(Registrant’s telephone number including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Exchange Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Stock, no par value |
PDEX |
NASDAQ Capital Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
| Emerging growth company ☐ |
|
If an emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item
1.01. Entry into a Material Definitive Agreement.
Acquisition
of Advance Precision Machining
On
February 9, 2026, Pro-Dex, Inc. (“Pro-Dex” or the “Company”) completed its acquisition of all the issued and outstanding
membership interests (the “Acquisition”) of Advanced Precision Machining LLC, a California limited liability company (“APM”),
resulting in APM becoming a wholly owned subsidiary of the Company. APM is engaged in the manufacture of various machined components serving
customers in a variety of industries, including medical device and aerospace, and manufactures several of the Company’s machined
sub-assemblies. The Acquisition was made pursuant to a Membership Interest Purchase Agreement, dated February 9, 2026 (the “Purchase
Agreement”), by and among the Company as purchaser, Advanced-Precision Machining Holding Company, Inc., a California corporation,
as seller (“Seller”), and Sean McCaig and Yasumi McCaig, each an individual, as the owners of Seller (“Owners”
and, together with Seller, the “Seller Parties”).
The
aggregate purchase price for the Acquisition was approximately $8,650,000, of which approximately $6,650,000 was paid by the Company in
cash at closing and $2,000,000 of which is to be paid by the Company under the terms of a 63-month subordinated promissory note issued
to Seller at closing (the “Seller Promissory Note”), which bears simple interest at 8% per annum and requires twenty-one equal
quarterly payments of principal and accrued interest in the amount on $117,569.54 each. The Company’s obligations under the Seller
Promissory Note are subordinate to the Company’s borrowings from UMB Bank N.A., described below. In connection with the Acquisition,
the Company also agreed to engage Sean McCaig as a consultant to provide the Company with various consulting services through the end
of calendar 2026.
The
Purchase Agreement contains representations, warranties, covenants, and indemnification obligations of the Company and the Seller Parties
customary for an acquisition transaction of this type. Pursuant to the terms of the Purchase Agreement, the Company will obtain a representations
and warranties insurance policy with a coverage amount of $2,000,000, which serves, to the extent covered by the policy, as a source of
recovery for indemnification claims the Company may have against the Seller Parties for breaches of representations or warranties under
the Purchase Agreement. The Seller Promissory Note also contains covenants and obligations of the Company customary for a subordinated
promissory note of this type.
The
foregoing description of the Purchase Agreement and the Seller Promissory Note and the transactions contemplated thereby is not complete
and is qualified in its entirety by reference to the full text of the Purchase Agreement and the Seller Promissory Note, copies of which
are filed as Exhibit 2.1 and Exhibit 10.1, respectively, to this Current Report on Form 8-K and are incorporated by reference
herein.
The
representations and warranties contained in the Purchase Agreement were made only for purposes of the transactions represented thereby
as of the specific dates therein, are solely for the benefit of the Company and Seller Parties, may be subject to limitations agreed upon
by the Company and Seller Parties, including, among others, being qualified by confidential disclosures made for the purposes of allocating
contractual risk between the parties instead of establishing these matters as facts, and may be subject to standards of materiality applicable
to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Purchase
Agreement and should not rely on the representations or warranties therein, or any descriptions thereof, as characterizations of the actual
state of facts or condition of the Company or any third party. Moreover, information concerning the subject matter of representations
and warranties contained in the Purchase Agreement may change after the date of the Purchase Agreement, which subsequent information may
or may not be fully reflected in the Company’s public disclosures. Rather, investors and the public should look to the disclosures
contained in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for information
concerning the Company.
UMB Second Amended
and Restated Credit & Security Agreement & Term Note D
In
connection with the Acquisition, on February 9, 2026 (the “Credit Amendment Date”), the Company entered into a Second Amended
and Restated Credit and Security Agreement (the “Amended Credit Agreement”) with UMB Bank, N.A. (“UMB”), which
among other things provided for financing to fund the cash portion of the purchase price for the Acquisition by issuing Term Note D in
the principal amount of $6,650,000. Term Note D is in addition to the following loans that were previously issued to the Company under
the UMB credit agreement and that remain issued under the Amended Credit Agreement: Term Note A in the original principal amount of $7,525,000,
Term Note B in the original principal amount of $1,000,000, Term Note C in the original principal amount of $5,000,000, and a Revolving
Note in the amount of $11,000,000.
The
Amended Credit Agreement also extended the maturity date of the Revolving Note from December 29, 2026 to December 29, 2027 pursuant
to a Third Amended and Restated Revolving Credit Note entered into by the Company and UMB on the Credit Amendment Date. No amounts are
drawn under the Revolving Note as of the date of this Current Report on Form 8-K.
Other
than the issuance of Term Note D and extension of the maturity date of the Revolving Note, the Amended Credit Agreement did not materially
amend or modify the terms of the Company’s loans with UMB as they existed prior to the Credit Amendment Date.
Both
Term Note A and Term Note B mature on November 1, 2027, and bear interest at a fixed rate of 3.84% per annum. Term Note C matures on August
1, 2029, and bears interest at the greater of (a) 5% or (b) the SOFR one-month rate plus 2.5% (the “Adjusted SOFR Rate”).
Term Note D matures on February 1, 2031, and bears interest at the greater of (a) 4.5% or (b) the Adjusted SOFR Rate. The Revolving Note
bears interest at the greater of (a) 4% or (b) the Adjusted SOFR Rate.
Any
payment on Term Note A, Term Note B, Term Note C, Term Note D or the Revolving Note (collectively, the “Notes”) not made within
seven days after the due date is subject to a late payment fee equal to 5% of the overdue amount. Upon the occurrence and during the continuance
of an event of default, the interest rate of all the Notes is increased by 3% and UMB may, at its option, declare the loans under the
Notes immediately due and payable in full. The origination fees associated with Term Note D in the amount of $16,625 and the maturity
extension fees associated with the Revolving Note in the amount of $15,000 were paid by the Company to UMB on the Credit Amendment Date.
The
Amended Credit Agreement and the Notes contain representations and warranties, affirmative, negative and financial covenants, and events
of default that are customary for loans of this type.
The
foregoing description of the Amended Credit Agreement and the Notes and the transactions contemplated thereby is not complete and is qualified
in its entirety by reference to the full text of the Amended Credit Agreement and the Notes. Copies of the Amended Credit Agreement, Term
Note D, and the Third Amended and Restated Revolving Credit Note are filed as Exhibit 10.2, Exhibit 10.3, and Exhibit 10.4,
respectively, to this Current Report on Form 8-K and are incorporated by reference herein. Copies of the current Term Note A, Term Note
B, and Term Note C are exhibits to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on
September 4, 2026 and are incorporated by reference herein.
The
representations and warranties contained in the Amended Credit Agreement and the Notes were made only for purposes of the transactions
represented thereby as of the specific dates therein, are solely for the benefit of the Company and UMB, may be subject to limitations
agreed upon by the Company and UMB, including, among others, being qualified by confidential disclosures made for the purposes of allocating
contractual risk between the parties instead of establishing these matters as facts, and may be subject to standards of materiality applicable
to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Amended
Credit Agreement or the Notes and should not rely on the representations or warranties therein, or any descriptions thereof, as characterizations
of the actual state of facts or condition of the Company or any third party. Moreover, information concerning the subject matter of representations
and warranties contained in the Amended Credit Agreement and the Notes may change after the date of those documents, which subsequent
information may or may not be fully reflected in the Company’s public disclosures. Rather, investors and the public should look
to the disclosures contained in the Company’s reports under the Exchange Act for information concerning the Company.
Item
2.01. Completion of Acquisition or Disposition of Assets.
The
disclosures contained in Item 1.01 above under the heading “Acquisition of Advanced Precision Machining”
are incorporated into this Item 2.01 by this reference.
Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The
disclosures contained in Item 1.01 above under the heading “UMB Second Amended and Restated Credit & Security Agreement
& Term Note D” are incorporated into this Item 2.03 by this reference.
Item
7.01. Regulation FD Disclosure.
Press
Release
A
copy of the press release announcing the Acquisition referenced in Item 1.01 above under the heading “Acquisition of Advanced
Precision Machining” is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The
information furnished pursuant to this Item 7.01 and the press release furnished as Exhibit 99.1 hereto shall not be deemed to be “filed”
for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall such information be
deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
| Exhibit Number |
|
Description |
2.1*±
|
|
Membership Interest Purchase Agreement dated February 9, 2026 by and among Pro-Dex, Inc., Advanced-Precision Machining Holding Company, Inc., and Sean McCaig and Yasumi McCaig
|
| 10.1 |
|
Subordinated Promissory Note dated February 9, 2026 between Pro-Dex, Inc. and Advanced-Precision Machining Holding Company, Inc. |
| 10.2* |
|
Second Amended and Restated Credit and Security Agreement dated February 9, 2026 by and among UMB Bank, N.A. and Pro-Dex, Inc. |
| 10.3 |
|
Term Note D dated February 9, 2026 made by Pro-Dex, Inc. in favor of UMB Bank, N.A. |
| 10.4 |
|
Third Amended and Restated Revolving Credit Note dated February 9, 2026 made by Pro-Dex, Inc. in favor of UMB Bank, N.A. |
| 99.1 |
|
Press Release dated February 12, 2026 |
| 104 |
|
Cover Page Interactive Data File (the cover page XBRL
tags are embedded within the inline XBRL document) |
*
Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the Securities and Exchange Commission, certain schedules and attachments to this exhibit have
been omitted because they do not contain information material to an investment or voting decision and that information is not otherwise
disclosed in the exhibit.
± Certain portions
of this exhibit have been redacted pursuant to Item 601(a)(6) or Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish
supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: February 12, 2026 |
Pro-Dex, Inc. |
| |
|
| |
|
|
| |
By: |
/s/ Alisha K. Charlton |
| |
|
Alisha K. Charlton |
| |
|
Chief Financial Officer |
Exhibit 99.1

Contact: Richard L. Van Kirk, Chief
Executive Officer
(949) 769-3200
For Immediate Release
PRO-DEX, INC. ANNOUNCES ACQUISITION OF
ADVANCED PRECISION MACHINING
IRVINE,
CA, February 12, 2026 - PRO-DEX, INC. (NasdaqCM: PDEX) today announced that on February 9, 2026
it completed its acquisition of Advanced Precision Machining LLC, (“APM”), formerly operated as Advanced Precision Machining,
Inc., a manufacturing facility located in Costa Mesa, Calif. APM manufactures several of our machined sub-assemblies and also produces
parts and assemblies for aerospace and defense systems. In addition, it serves as a Prime Contractor for the U.S. Government and therefore
maintains registrations under the International Traffic in Arms Regulations (“ITAR”) as well as a Joint Certification Program
(“JCP”) certification. We anticipate that we will operate APM independently of Pro-Dex and therefore,
due to the length of their accounting close, we anticipate that our future consolidated results of operations will likely be announced
closer to or on our statutory Securities and Exchange Commission deadlines.
“We are excited that
APM is joining the Pro-Dex family,” said Rick Van Kirk, President and CEO of Pro-Dex. “APM has been a quality supplier of
ours for several decades and we look forward to applying some of APM’s leading edge automation and technology to streamline our
manufacturing and assembly operations in Irvine.”
Mr. Van Kirk continued, “This
transaction is part of our expansion plans based upon the recently announced contract extension with our largest customer and resultant
expectant revenue growth. Additionally, we anticipate maintaining and expanding APM’s business with other industries.”
About
Pro-Dex, Inc.:
Pro-Dex, Inc.
specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers
and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting
software and proprietary sealing solutions that appeal to our customers, primarily medical device distributors. Additionally, we provide
engineering, quality, and regulatory consulting services to our customers. We also manufacture and sell rotary air motors to a wide range
of industries; however, these motors comprise a de minimis portion of our business. For more information, visit the Company's website
at www.pro-dex.com.
Statements herein concerning
the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws.
Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs,
plans, estimates or projections relating to the future (including, without limitation, expected revenue growth and the ability maintain
and expand APM’s business), are forward-looking statements within the meaning of these laws. The Company's actual results may differ
materially from those suggested as a result of various factors. The risks included above are not exhaustive. For a more detailed description
of risks associated with the Company, interested parties should refer to the risk factors and other disclosures concerning the operational
and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.